Here are five things to know about the sale:
1. K2M sold 906,748 shares of common stock in their follow-on offering pursuant to the underwriters’ option to purchase additional shares.
2. The shares were purchased at $18.75 per share before underwriting discounts.
3. K2M didn’t receive any proceeds from the sale.
4. Piper Jaffray & Co., Barclays Capital and Wells Fargo Securities are joint book-running managers for the offering.
5. William Blair & Company and Cowen and Company are co-managers.
There has also been a great deal of action for individuals selling stock over the past few days:
• John Philip Kostuik, MD, sold 83,807 shares in a $1.4 million transaction
• Director Ray A. Ranelli sold 14,000 shares in a $262,500 transaction
• Wcas Management sold 3,738 shares in a $70,087.50 transaction
More articles on orthopedic devices:
7 key trends in joint replacement customization
Smith & Nephew launches new suture anchor
Smith & Nephew launches new suture anchor
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
